IPSEF
Price
$113.13
Change
+$9.63 (+9.30%)
Updated
Jun 9 closing price
Capitalization
11.56B
IPSEY
Price
$34.85
Change
+$1.14 (+3.38%)
Updated
Sep 5 closing price
Capitalization
11.56B
46 days until earnings call
Interact to see
Advertisement

IPSEF vs IPSEY

Header iconIPSEF vs IPSEY Comparison
Open Charts IPSEF vs IPSEYBanner chart's image
Ipsen S.A
Price$113.13
Change+$9.63 (+9.30%)
Volume$150
Capitalization11.56B
Ipsen S.A
Price$34.85
Change+$1.14 (+3.38%)
Volume$1.47K
Capitalization11.56B
IPSEF vs IPSEY Comparison Chart in %
Loading...
IPSEY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
IPSEF vs. IPSEY commentary
Sep 06, 2025

To understand the difference between Ipsen (IPSEF) vs. Ipsen - ADR (IPSEY) it is enough to know the definitions of ADR

ADR - American depositary receipt (ADR) is a certificate issued by a U.S. depositary bank representing a specified number of shares (often 1 share) of a foreign company's stock. ADRs are denominated in U.S. dollars and trade on U.S. stock markets and OTC depending on the ADRs classification.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 06, 2025
Stock price -- (IPSEF: $113.13 vs. IPSEY: $34.85)
Brand notoriety: IPSEF and IPSEY are both not notable
Both companies represent the Pharmaceuticals: Generic industry
Current volume relative to the 65-day Moving Average: IPSEF: 100% vs. IPSEY: 167%
Market capitalization -- IPSEF: $11.56B vs. IPSEY: $11.56B
IPSEF [@Pharmaceuticals: Generic] is valued at $11.56B. IPSEY’s [@Pharmaceuticals: Generic] market capitalization is $11.56B. The market cap for tickers in the [@Pharmaceuticals: Generic] industry ranges from $67.95B to $0. The average market capitalization across the [@Pharmaceuticals: Generic] industry is $3.94B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

IPSEF’s FA Score shows that 2 FA rating(s) are green whileIPSEY’s FA Score has 2 green FA rating(s).

  • IPSEF’s FA Score: 2 green, 3 red.
  • IPSEY’s FA Score: 2 green, 3 red.
According to our system of comparison, IPSEY is a better buy in the long-term than IPSEF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

IPSEY’s TA Score shows that 5 TA indicator(s) are bullish.

  • IPSEY’s TA Score: 5 bullish, 4 bearish.

Price Growth

IPSEF (@Pharmaceuticals: Generic) experienced а 0.00% price change this week, while IPSEY (@Pharmaceuticals: Generic) price change was +2.41% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was +0.10%. For the same industry, the average monthly price growth was +12.13%, and the average quarterly price growth was +87.01%.

Reported Earning Dates

IPSEY is expected to report earnings on Oct 22, 2025.

Industries' Descriptions

@Pharmaceuticals: Generic (+0.10% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
IPSEF($11.6B) and IPSEY($11.6B) have the same market capitalization . IPSEY has higher P/E ratio than IPSEF: IPSEY (22.26) vs IPSEF (18.07). IPSEY YTD gains are higher at: 21.901 vs. IPSEF (-9.763). IPSEF (1.3B) and IPSEY (1.3B) have comparable annual earnings (EBITDA) . IPSEF (1.45B) and IPSEY (1.45B) have equal amount of cash in the bank . IPSEF (869M) and IPSEY (869M) have identical debt. IPSEF (3.76B) and IPSEY (3.76B) have equivalent revenues.
IPSEFIPSEYIPSEF / IPSEY
Capitalization11.6B11.6B100%
EBITDA1.3B1.3B100%
Gain YTD-9.76321.901-45%
P/E Ratio18.0722.2681%
Revenue3.76B3.76B100%
Total Cash1.45B1.45B100%
Total Debt869M869M100%
FUNDAMENTALS RATINGS
IPSEF vs IPSEY: Fundamental Ratings
IPSEF
IPSEY
OUTLOOK RATING
1..100
4727
VALUATION
overvalued / fair valued / undervalued
1..100
26
Undervalued
31
Undervalued
PROFIT vs RISK RATING
1..100
3540
SMR RATING
1..100
9191
PRICE GROWTH RATING
1..100
5949
P/E GROWTH RATING
1..100
2213
SEASONALITY SCORE
1..100
1065

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

IPSEF's Valuation (26) in the null industry is in the same range as IPSEY (31). This means that IPSEF’s stock grew similarly to IPSEY’s over the last 12 months.

IPSEF's Profit vs Risk Rating (35) in the null industry is in the same range as IPSEY (40). This means that IPSEF’s stock grew similarly to IPSEY’s over the last 12 months.

IPSEF's SMR Rating (91) in the null industry is in the same range as IPSEY (91). This means that IPSEF’s stock grew similarly to IPSEY’s over the last 12 months.

IPSEY's Price Growth Rating (49) in the null industry is in the same range as IPSEF (59). This means that IPSEY’s stock grew similarly to IPSEF’s over the last 12 months.

IPSEY's P/E Growth Rating (13) in the null industry is in the same range as IPSEF (22). This means that IPSEY’s stock grew similarly to IPSEF’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
IPSEFIPSEY
RSI
ODDS (%)
N/A
Bearish Trend 1 day ago
68%
Stochastic
ODDS (%)
N/A
Bearish Trend 1 day ago
51%
Momentum
ODDS (%)
N/A
Bullish Trend 1 day ago
64%
MACD
ODDS (%)
N/A
Bullish Trend 1 day ago
69%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
17%
Bullish Trend 1 day ago
57%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
13%
Bullish Trend 1 day ago
56%
Advances
ODDS (%)
N/A
Bullish Trend 9 days ago
53%
Declines
ODDS (%)
N/A
Bearish Trend 4 days ago
43%
BollingerBands
ODDS (%)
N/A
Bearish Trend 1 day ago
65%
Aroon
ODDS (%)
N/A
Bullish Trend 1 day ago
47%
View a ticker or compare two or three
Interact to see
Advertisement
IPSEY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
HPI16.350.15
+0.93%
John Hancock Preferred Income Fund
JBND54.120.26
+0.48%
JPMorgan Active Bond ETF
AIEQ43.86-0.12
-0.28%
Amplify AI Powered Equity ETF
NRSH21.60-0.06
-0.29%
Aztlan NA Nearshoring Stk Sel ETF
LRGG29.56-0.31
-1.04%
Macquarie Focused Large Growth ETF

IPSEF and

Correlation & Price change

A.I.dvisor tells us that IPSEF and TEVJF have been poorly correlated (+24% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that IPSEF and TEVJF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IPSEF
1D Price
Change %
IPSEF100%
N/A
TEVJF - IPSEF
24%
Poorly correlated
N/A
IPSEY - IPSEF
6%
Poorly correlated
+3.39%
JUSHF - IPSEF
6%
Poorly correlated
+6.59%
INDV - IPSEF
5%
Poorly correlated
+1.01%
INIS - IPSEF
2%
Poorly correlated
N/A
More

IPSEY and

Correlation & Price change

A.I.dvisor tells us that IPSEY and LBTSF have been poorly correlated (+15% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that IPSEY and LBTSF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IPSEY
1D Price
Change %
IPSEY100%
+3.39%
LBTSF - IPSEY
15%
Poorly correlated
N/A
LVRLF - IPSEY
9%
Poorly correlated
+1.96%
HYPMY - IPSEY
7%
Poorly correlated
+1.57%
IPSEF - IPSEY
6%
Poorly correlated
N/A
INDV - IPSEY
5%
Poorly correlated
+1.01%
More